We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
AMSBIO Launches ELISA-like Assay for Hyaluronic Acid
Product News

AMSBIO Launches ELISA-like Assay for Hyaluronic Acid

AMSBIO Launches ELISA-like Assay for Hyaluronic Acid
Product News

AMSBIO Launches ELISA-like Assay for Hyaluronic Acid

Image Credit: AMSBIO

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "AMSBIO Launches ELISA-like Assay for Hyaluronic Acid "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy


AMSBIO announces the launch of a new Hyaluronic Acid Quantification Kit, based on a highly specific and tightly binding protein to detect and measure Hyaluronic Acid, also known as Hyaluronan or HA.


This product is a competitive ELISA-like kit using a recombinant Hyaluronic Acid Binding Protein (rHABP) optimized to quantify HA polymers of average molecular weight greater than 7.4 kDa in samples such as serum, plasma and culture supernatant.


Hyaluronic Acid (HA) is a Glycosaminoglycan (GAG)with a simple structure that is widely found in the extracellular matrix, and abundant in synovial fluid, skin, umbilical cord, and vitreous bodies; contributing to tissue water retention and to cellular growth, differentiation, and migration. Because of its simplicity and ubiquity, HA is not immunogenic so classical immunological analysis has not been possible. 


Recombinant HABP specifically detects Hyaluronic Acid (HA), binding to HA from all species and tissues. It does not cross-react with other GAG's or to DNA. Recombinant production means that rHABP offers intrinsically higher safety compared with animal-derived HABP.


Advertisement